Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-05 Sale | 2024-02-06 6:32 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 6,346 | $4.86 | $30,842 | 353,054 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:02 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 7,764 | $4.95 | $38,432 | 92,767 (Direct) | View |
| 2023-07-07 Sale | 2023-07-11 8:00 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 832 | $4.93 | $4,102 | 100,531 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:33 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 6,416 | $4.24 | $27,204 | 101,363 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-02 Option Award | 2024-08-06 4:10 pm | N/A 2034-08-01 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer | 44,010 | $0 | 44,010 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:50 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:32 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 266,633 | $0 | 353,054 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 6:19 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 7:34 pm | N/A 2033-01-29 | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 272,223 | $0 | 324,446 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-15 8:01 pm | N/A 2032-06-30 | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 56,667 | $0 | 122,223 (Direct) | View |
Ownership | 2022-07-11 8:55 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 0 | $0 | 302,223 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:12 pm | N/A 2032-03-16 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director | 80,000 | $0 | 80,000 (Direct) | View |
Ownership | 2022-03-18 5:11 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2020-06-25 7:14 pm | N/A 2029-10-17 | Akouos Inc. | AKUS | Ozden Rabia Gurses Chief Development Officer | 0 | $0 | 188,059 (Direct) | View |